Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sara, Chaothai"'
Autor:
Xiaofeng Mu, Carolyn A. Cohen, Daniel Leung, Jaime S. Rosa Duque, Samuel M. S. Cheng, Yuet Chung, Howard H. W. Wong, Amos M. T. Lee, Wing Yan Li, Issan Y. S. Tam, Jennifer H. Y. Lam, Derek H. L. Lee, Sau Man Chan, Leo C. H. Tsang, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Sara Chaothai, Kelvin K. H. Kwan, Nym Coco Chu, Masashi Mori, Trushar Jeevan, Ahmed Kandeil, Richard J. Webby, Wenwei Tu, Sophie A. Valkenburg, Malik Peiris, Yu Lung Lau
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 7, Iss 1, Pp 1-10 (2022)
Abstract The high effectiveness of the third dose of BNT162b2 in healthy adolescents against Omicron BA.1 has been reported in some studies, but immune responses conferring this protection are not yet elucidated. In this analysis, our study (NCT04800
Externí odkaz:
https://doaj.org/article/cbb87e487bc041848913a814dedbe2d2
Autor:
Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, Asmaa Hachim, Yanmei Zhang, Sau Man Chan, Sara Chaothai, Kelvin K. H. Kwan, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Leo C. H. Tsang, Wilfred H. S. Wong, Cheuk Hei Cheang, Timothy K. Hung, Jennifer H. Y. Lam, Gilbert T. Chua, Winnie W. Y. Tso, Patrick Ip, Masashi Mori, Niloufar Kavian, Wing Hang Leung, Sophie Valkenburg, Malik Peiris, Wenwei Tu, Yu Lung Lau
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
There are adverse events associated with COVID-19 vaccines, such as myocarditis for adolescents following receipt of SARS-CoV-2 mRNA vaccines. Here the authors compare the immunogenicity and reactogenicity of two widely available SARS-CoV-2 vaccines
Externí odkaz:
https://doaj.org/article/f4b9f38e2cf744f5a91a3b8ac36a6c70
Autor:
Daniel Leung, Carolyn A. Cohen, Xiaofeng Mu, Jaime S. Rosa Duque, Samuel M. S. Cheng, Xiwei Wang, Manni Wang, Wenyue Zhang, Yanmei Zhang, Issan Y. S. Tam, Jennifer H. Y. Lam, Sau Man Chan, Sara Chaothai, Kelvin K. H. Kwan, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Leo C. H. Tsang, Nym Coco Chu, Wilfred H. S. Wong, Masashi Mori, Wing Hang Leung, Sophie Valkenburg, Malik Peiris, Wenwei Tu, Yu Lung Lau
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionTwo doses of inactivated SARS-CoV-2 vaccine CoronaVac cannot elicit high efficacy against symptomatic COVID-19, especially against the Omicron variant, but that can be improved by a third dose in adults. The use of a third dose of CoronaV
Externí odkaz:
https://doaj.org/article/d01897681a6043d09727b5d24eb8e7ff
Autor:
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, Samuel M. S. Cheng, Manni Wang, Wenyue Zhang, Yanmei Zhang, Issan Y. S. Tam, Toby S. S. Lee, Jennifer H. Y. Lam, Sau Man Chan, Cheuk Hei Cheang, Yuet Chung, Howard H. W. Wong, Amos M. T. Lee, Wing Yan Li, Sara Chaothai, Leo C. H. Tsang, Gilbert T. Chua, Kai-Ning Cheong, Elaine Y. L. Au, Janette S. Y. Kwok, Koon Wing Chan, Patrick C. Y. Chong, Pamela P. W. Lee, Marco H. K. Ho, Tsz Leung Lee, Wenwei Tu, Malik Peiris, Yu Lung Lau
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Our study (NCT04800133) aimed to determine the safety and immunogenicity in patients with IEIs receiving a 3-dose primary series of mRNA vaccine BNT162b2 (age 12+) or inactivated whole-virion vaccine CoronaVac (age 3+) in Hong Kong, including Omicron
Externí odkaz:
https://doaj.org/article/40439ee79362418ba1ea1faa97dea241
Autor:
Eric HY Lau, David SC Hui, Owen TY Tsang, Wai-Hung Chan, Mike YW Kwan, Susan S Chiu, Samuel MS Cheng, Ronald LW Ko, John KC Li, Sara Chaothai, Chi H Tsang, Leo LM Poon, Malik Peiris
Publikováno v:
EClinicalMedicine, Vol 41, Iss , Pp 101174- (2021)
Background: The duration of immunity in SARS-CoV-2 infected people remains unclear. Neutralizing antibody responses are the best available correlate of protection against re-infection. Recent studies estimated that the correlate of 50% protection fro
Externí odkaz:
https://doaj.org/article/d862135204d1410cbb753e418d24ab9e
Autor:
Jaime S. Rosa Duque, Xiwei Wang, Daniel Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Xiaofeng Mu, Asmaa Hachim, Yanmei Zhang, Sau Man Chan, Sara Chaothai, Kelvin K. H. Kwan, Karl C. K. Chan, John K. C. Li, Leo L. H. Luk, Leo C. H. Tsang, Wilfred H. S. Wong, Cheuk Hei Cheang, Timothy K. Hung, Jennifer H. Y. Lam, Gilbert T. Chua, Winnie W. Y. Tso, Patrick Ip, Masashi Mori, Niloufar Kavian, Wing Hang Leung, Sophie Valkenburg, Malik Peiris, Wenwei Tu, Yu Lung Lau
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/e0161bcd3cb542a29c245989383f4cf8
Autor:
Jonathan J. Lau, Samuel M. S. Cheng, Kathy Leung, Cheuk Kwong Lee, Asmaa Hachim, Leo C. H. Tsang, Kenny W. H. Yam, Sara Chaothai, Kelvin K. H. Kwan, Zacary Y. H. Chai, Tiffany H. K. Lo, Masashi Mori, Chao Wu, Sophie A. Valkenburg, Gaya K. Amarasinghe, Eric H. Y. Lau, David S. C. Hui, Gabriel M. Leung, Malik Peiris, Joseph T. Wu
Publikováno v:
Nature Medicine. 29:348-357
The SARS-CoV-2 Omicron variant has demonstrated enhanced transmissibility and escape of vaccine-derived immunity. Although first-generation vaccines remain effective against severe disease and death, robust evidence on vaccine effectiveness (VE) agai
Autor:
Nancy H L Leung, Samuel M S Cheng, Mario Martín-Sánchez, Niki Y M Au, Yvonne Y Ng, Leo L H Luk, Karl C K Chan, John K C Li, Yonna W Y Leung, Leo C H Tsang, Sara Chaothai, Kelvin K H Kwan, Dennis K M Ip, Leo L M Poon, Gabriel M Leung, J S Malik Peiris, Benjamin J Cowling
Publikováno v:
Clinical Infectious Diseases. 76:e299-e307
Background Limited data exist on antibody responses to mixed vaccination strategies that involve inactivated coronavirus disease 2019 (COVID-19) vaccines, particularly in the context of emerging variants. Methods We conducted an open-label trial of a
Autor:
Jaime S. Rosa Duque, Samuel M.S. Cheng, Carolyn A. Cohen, Daniel Leung, Xiwei Wang, Xiaofeng Mu, Yuet Chung, Tsun Ming Lau, Manni Wang, Wenyue Zhang, Yanmei Zhang, Howard H.W. Wong, Leo C.H. Tsang, Sara Chaothai, Tsz Chun Kwan, John K.C. Li, Karl C.K. Chan, Leo L.H. Luk, Jenson C.H. Ho, Wing Yan Li, Amos M.T. Lee, Jennifer H.Y. Lam, Sau Man Chan, Wilfred H.S. Wong, Issan Y.S. Tam, Masashi Mori, Sophie A. Valkenburg, Malik Peiris, Wenwei Tu, Yu Lung Lau
Strategies to improve the immunogenicity of COVID-19 vaccines are necessary to optimise their protection against disease. Fractional dosing by intradermal administration (ID) has been shown to be equally immunogenic as intramuscular (IM) for several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::719cf1e3b938a8136938e7c16162d51f
https://doi.org/10.1101/2023.04.05.23288005
https://doi.org/10.1101/2023.04.05.23288005
Autor:
Jonathan J Lau, Samuel MS Cheng, Kathy Leung, Cheuk Kwong Lee, Asmaa Hachim, Leo CH Tsang, Kenny WH Yam, Sara Chaothai, Kelvin KH Kwan, Zacary YH Chai, Tiffany HK Lo, Masashi Mori, Chao Wu, Sophie Valkenburg, Gaya K Amarasinghe, Eric HY Lau, David S Hui, Gabriel M Leung, Malik Peiris, Joseph T Wu
The SARS-CoV-2 Omicron variant has demonstrated enhanced transmissibility and escape of vaccine-derived immunity. While current vaccines remain effective against severe disease and death, robust evidence on vaccine effectiveness (VE) against all Omic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::825c9f7ab769deced37ef7ddf2c1667d
https://doi.org/10.1101/2022.11.01.22281746
https://doi.org/10.1101/2022.11.01.22281746